Distribution characteristics of hepatitis B serological markers in hospitalized children and adolescents in Zhejiang, China between 2006 and 2010

Gut and Liver

Volumn 5, Issue 2, 2011, Pages 210-216

  Chen, Xuejun ^a   Shen, Yuefang ^a   Xiang, Wenqing ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chemiluminescent measurements; Children; Epidemiologic studies; Hepatitis B antibodies; Immunoassay

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHINA; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROCHEMILUMINESCENT IMMUNOASSAY; FEMALE; HEPATITIS B; HUMAN; IMMUNOASSAY; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PEDIATRICS; PRESCHOOL CHILD; SCHOOL CHILD; SEROLOGY; VACCINATION;

EID: 79959342670     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2011.5.2.210     Document Type: Article

References (26)

1. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004;38(10 Suppl 3):S158-S168.
2. McCartney RA, Harbour J, Roome AP, Caul EO. Comparison of enhanced chemiluminescence and microparticle enzyme immunoassay for the measurement of hepatitis B surface antibody. Vaccine 1993;11:941-945. (Pubitemid 23218803)
3. Diepersloot RJ, van Zantvliet-van Oostrom Y, Gleaves CA. Comparison of a chemiluminescent immunoassay with two microparticle enzyme immunoassays for detection of hepatitis B virus surface antigen. Clin Diagn Lab Immunol 2000;7:865-866. (Pubitemid 32244479)
4. Huh HJ, Chae SL, Cha YJ. Comparison study with enzyme immunoassay and chemiluminescence immunoassay for hepatitis B virus surface antigen detection. Korean J Lab Med 2007;27:355-359.
5. Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J (Engl) 2009;122:3-4.
6. Mushahwar IK, Dienstag JL, Polesky HF, McGrath LC, Decker RH, Overby LR. Interpretation of various serological profiles of hepatitis B virus infection. Am J Clin Pathol 1981;76:773-777. (Pubitemid 12247781)
7. Irshad M. Interpretation of serological markers of hepatitis viruses. Trop Gastroenterol 1995;16:4-10.
8. Mujeeb SA, Ansari N, Ahmed A. Serological markers of hepatitis B infection: a study to reduce cost and improve interpretation. Infect Dis J Pakistan 2007;16:17-19.
9. Alhababi F, Sallam TA, Tong CY. The significance of 'anti-HBc only' in the clinical virology laboratory. J Clin Virol 2003;27:162-169.
10. Knöll A, Hartmann A, Hamoshi H, Weislmaier K, Jilg W. Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance. World J Gastroenterol 2006;12:1255-1260.
11. Wang Z, Zhang J, Yang H, et al. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol 2003;71:360-366. (Pubitemid 37176624)
12. Qiu L, Binns CW, Zhao Y, Zhang K, Xie X. Hepatitis B and breast-feeding in Hangzhou, Zhejiang Province, People's Republic of China. Breastfeed Med 2010;5:109-112.
13. Patterson W, Werness P, Payne WJ, et al. Random and continuous- access immunoassays with chemiluminescent detection by Access automated analyzer. Clin Chem 1994;40(11 Pt 1):2042-2045. (Pubitemid 24346171)
14. Hadler SC, Margolis HS. Hepatitis B immunization: vaccine types, efficacy, and indications for immunization. Curr Clin Top Infect Dis 1992;12:282-308.
15. Köksal N, Altinkaya N, Perk Y. Transient hepatitis B surface antigenemia after neonatal hepatitis B immunization. Acta Paediatr 1996;85:1501-1502. (Pubitemid 26411418)
16. Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of hepatitis B in China: declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009;27:6550-6557.
17. El-Magrahe H, Furarah AR, El-Figih K, El-Urshfany S, Ghenghesh KS. Maternal and neonatal seroprevalence of Hepatitis B surface antigen (HBsAg) in Tripoli, Libya. J Infect Dev Ctries 2010;4:168-170.
18. Utsumi T, Yano Y, Lusida MI, et al. Serologic and molecular characteristics of hepatitis B virus among school children in East Java, Indonesia. Am J Trop Med Hyg 2010;83:189-193.
19. Alikor EA, Erhabor ON. Seroprevalence of hepatitis B surface antigenaemia in children in a tertiary health institution in the Niger Delta of Nigeria. Niger J Med 2007;16:326-329.
20. Liang X, Bi S, Yang W, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 2009;200:39-47.
21. Gold Y, Somech R, Mandel D, Peled Y, Reif S. Decreased immune response to hepatitis B eight years after routine vaccination in Israel. Acta Paediatr 2003;92:1158-1162. (Pubitemid 37297095)
22. Poland GA, Jacobson RM. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 2004;351:2832-2838. (Pubitemid 40051907)
23. Zhang L, Xu AQ, Yan BY. Analysis on hepatitis B vaccine coverage among the population of 1-59 years old in Shandong province. Zhongguo Yi Miao He Mian Yi 2009;15:159-162.
24. Lu JJ, Cheng CC, Chou SM, Hor CB, Yang YC, Wang HL. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan. Vaccine 2009;27:6613-6618.
25. Zhou YH, Wu C, Zhuang H. Vaccination against hepatitis B: the Chinese experience. Chin Med J (Engl) 2009;122:98-102.
26. Dong Y, Liu SL, Zhai XJ, et al. A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China. J Med Virol 2009;81:1517-1524.